Joel Ho

Joel Ho, MD, is a board-certified medical oncologist specializing in solid tumors, particularly melanoma and genitourinary cancers, as well as immune-oncology and cellular therapies. They have clinical experience gained through fellowships at BC Cancer and MD Anderson Cancer Center, where they focused on patient safety protocols and innovative treatments. Currently serving as an Associate Medical Director at Pfizer, Joel continues to oversee clinical trials and collaborate with key opinion leaders in oncology. They have also contributed academically as an Assistant Professor at Fred Hutch, managing clinical trials and guiding research initiatives. Joel holds a Doctor of Medicine degree from The University of British Columbia and a Clinical Quality Improvement Certificate from MD Anderson Cancer Center.